Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in | Journal of Virology Vol. 87; no. 12; pp. 6604 - 6614 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.06.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized
ex vivo
cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung
ex vivo
organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in
ex vivo
respiratory tissue cultures. Treatment of human lung tissue
ex vivo
organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection. Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized ex vivo cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung ex vivo organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in ex vivo respiratory tissue cultures. Treatment of human lung tissue ex vivo organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection.Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized ex vivo cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung ex vivo organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in ex vivo respiratory tissue cultures. Treatment of human lung tissue ex vivo organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized ex vivo cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung ex vivo organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in ex vivo respiratory tissue cultures. Treatment of human lung tissue ex vivo organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection. |
Author | Joanne H. M. Fong Renee W. Y. Chan Louisa L. Y. Chan Leo L. M. Poon Denise I. T. Kuok John M. Nicholls Y. Guan Michael C. W. Chan Ralph S. Baric Sudhakar Agnihothram J. S. Malik Peiris |
Author_xml | – sequence: 1 givenname: Renee W. Y. surname: Chan fullname: Chan, Renee W. Y. organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China – sequence: 2 givenname: Michael C. W. surname: Chan fullname: Chan, Michael C. W. organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China – sequence: 3 givenname: Sudhakar surname: Agnihothram fullname: Agnihothram, Sudhakar organization: Departments of Epidemiology and Microbiology and Immunology, Gillings School of Global Public Health, and School of Medicine, The University of North Carolina, Chapel Hill, North Carolina, USA – sequence: 4 givenname: Louisa L. Y. surname: Chan fullname: Chan, Louisa L. Y. organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China – sequence: 5 givenname: Denise I. T. surname: Kuok fullname: Kuok, Denise I. T. organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China – sequence: 6 givenname: Joanne H. M. surname: Fong fullname: Fong, Joanne H. M. organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China – sequence: 7 givenname: Y. surname: Guan fullname: Guan, Y. organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China – sequence: 8 givenname: Leo L. M. surname: Poon fullname: Poon, Leo L. M. organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China – sequence: 9 givenname: Ralph S. surname: Baric fullname: Baric, Ralph S. organization: Departments of Epidemiology and Microbiology and Immunology, Gillings School of Global Public Health, and School of Medicine, The University of North Carolina, Chapel Hill, North Carolina, USA – sequence: 10 givenname: John M. surname: Nicholls fullname: Nicholls, John M. organization: Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China – sequence: 11 givenname: J. S. Malik surname: Peiris fullname: Peiris, J. S. Malik organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23552422$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkktvEzEUhS1URNPCjjWyWLFgip-TyQYJopYGRVRCpWJn3czcSVzN2MH2hPYH8L9xHlSAhPDGj_vdo2P7nJAj5x0S8pyzM85F9ebjzeyM5TEpuHxERpxNqkJrro7IiDEhCi2rr8fkJMZbxrhSpXpCjoXUWighRuTHdfBrG3vqWwquoTPnICGd9f3gkH7GuPYuYqTJ07RC-slvsKOXQw-OvscEtQ_ewcaGIdK5dQhLpFN6s9tbdwDP7_LJxu_UbIDkwz29CstcmQ5dGgLGp-RxC13EZ4f5lHy5OL-eXhbzqw-z6bt5USulUiEBpFhwhRLUotECmNKSV02T17qGBkEw0K0oaykqLfW41gvJsBUNl-MJ0_KUvN3rrodFj02NLgXozDrYHsK98WDNnxVnV2bpN0aW45LzrcCrg0Dw3waMyfQ21th14NAP0eQHlnIsGav-j0pdTnT2LzL64ndbD35-fVMGXu-BOvgYA7YPCGdmmwKTU2B2Kci6GRd_4bVNkKzfXsp2_2p6uW9a2eXquw1oIPbmdmNNNTZcmLJkSv4EcGvBXw |
CitedBy_id | crossref_primary_10_1128_JVI_03427_14 crossref_primary_10_1111_2049_632X_12166 crossref_primary_10_21307_PM_2018_57_1_022 crossref_primary_10_1099_vir_0_061911_0 crossref_primary_10_1016_j_intimp_2020_107171 crossref_primary_10_1074_jbc_M114_609644 crossref_primary_10_1038_srep35401 crossref_primary_10_1146_annurev_med_051215_031152 crossref_primary_10_2217_fvl_2016_0060 crossref_primary_10_1186_s12879_016_1492_4 crossref_primary_10_1016_S1473_3099_14_70828_X crossref_primary_10_1128_JVI_03607_14 crossref_primary_10_1128_mBio_00650_13 crossref_primary_10_1016_j_bbalip_2020_158849 crossref_primary_10_1016_j_virol_2014_02_018 crossref_primary_10_1016_S1473_3099_13_70159_2 crossref_primary_10_1097_MCP_0000000000000046 crossref_primary_10_1093_jac_dkw338 crossref_primary_10_1016_j_antiviral_2018_05_007 crossref_primary_10_1016_S1473_3099_13_70154_3 crossref_primary_10_5897_JVMAH2015_0454 crossref_primary_10_4049_jimmunol_1901489 crossref_primary_10_1371_journal_ppat_1009229 crossref_primary_10_1016_j_ijbiomac_2021_02_070 crossref_primary_10_1128_mBio_01174_14 crossref_primary_10_1016_j_jbc_2022_101635 crossref_primary_10_12998_wjcc_v9_i19_5135 crossref_primary_10_1089_jir_2020_0187 crossref_primary_10_1016_S2213_2600_13_70138_3 crossref_primary_10_1016_j_jfma_2013_05_010 crossref_primary_10_3389_fvets_2019_00034 crossref_primary_10_1099_vir_0_055533_0 crossref_primary_10_1007_s00251_022_01261_w crossref_primary_10_1016_j_csbj_2024_01_009 crossref_primary_10_1126_sciadv_aao4966 crossref_primary_10_1128_JVI_01055_13 crossref_primary_10_1186_s12985_024_02332_y crossref_primary_10_1038_s41556_021_00710_0 crossref_primary_10_1016_j_cytogfr_2014_06_005 crossref_primary_10_1186_s13054_016_1234_4 crossref_primary_10_1007_s15010_013_0509_9 crossref_primary_10_1371_journal_ppat_1003595 crossref_primary_10_3390_v14010164 crossref_primary_10_1002_rmv_2206 crossref_primary_10_1073_pnas_1619109114 crossref_primary_10_1128_JVI_02143_16 crossref_primary_10_3389_fphar_2020_600369 crossref_primary_10_1038_s41598_017_11736_6 crossref_primary_10_1128_mBio_00531_13 crossref_primary_10_1016_j_antiviral_2013_10_002 crossref_primary_10_1016_S0140_6736_15_60454_8 crossref_primary_10_17816_brmma72051 crossref_primary_10_1074_jbc_AC120_013788 crossref_primary_10_1093_infdis_jit328 crossref_primary_10_1007_s13365_021_00998_6 crossref_primary_10_1016_j_antiviral_2015_07_005 crossref_primary_10_1007_s11356_021_12553_1 crossref_primary_10_1038_s44298_024_00018_4 crossref_primary_10_1093_cvr_cvaa209 crossref_primary_10_1177_03009858221095270 crossref_primary_10_1073_pnas_1310744110 crossref_primary_10_1093_infdis_jit609 crossref_primary_10_3390_v15040907 crossref_primary_10_1002_rmv_1748 crossref_primary_10_1016_j_ccc_2013_07_003 crossref_primary_10_1128_AAC_03011_14 crossref_primary_10_3201_eid2203_151437 crossref_primary_10_3390_cells10030530 crossref_primary_10_1186_s12931_017_0567_0 crossref_primary_10_1007_s13238_013_3096_8 crossref_primary_10_1038_nrd_2015_37 crossref_primary_10_1371_journal_ppat_1006838 crossref_primary_10_1177_17534666231162252 crossref_primary_10_2217_fvl_2018_0201 crossref_primary_10_1016_j_biopha_2021_111352 crossref_primary_10_1208_s12249_021_02062_2 crossref_primary_10_4049_immunohorizons_2200065 crossref_primary_10_1128_JVI_03649_13 crossref_primary_10_1128_CMR_00102_14 crossref_primary_10_1073_pnas_1323279111 crossref_primary_10_3389_fimmu_2024_1358885 crossref_primary_10_1016_j_antiviral_2013_08_015 crossref_primary_10_1038_emi_2016_33 crossref_primary_10_1186_s13567_016_0354_9 crossref_primary_10_3389_fimmu_2018_00205 crossref_primary_10_1371_journal_ppat_1008737 crossref_primary_10_1016_j_ccm_2016_11_007 crossref_primary_10_1016_j_coviro_2014_03_011 crossref_primary_10_1016_S2213_2600_20_30193_4 crossref_primary_10_1016_j_arr_2020_101234 crossref_primary_10_1093_infdis_jit504 crossref_primary_10_3390_pathogens9120989 crossref_primary_10_1146_annurev_pathol_012414_040501 crossref_primary_10_12688_f1000research_11827_1 crossref_primary_10_12688_f1000research_25390_1 crossref_primary_10_1371_journal_ppat_1005982 crossref_primary_10_1155_2019_6491738 crossref_primary_10_1016_S2213_2600_14_70158_4 crossref_primary_10_3389_fpubh_2021_756049 crossref_primary_10_1073_pnas_1311542110 crossref_primary_10_1128_JVI_00676_14 crossref_primary_10_1093_cid_ciaa453 crossref_primary_10_1016_j_virusres_2015_01_021 crossref_primary_10_1186_1471_2164_15_1161 crossref_primary_10_1186_s12985_015_0446_6 crossref_primary_10_1002_path_4458 crossref_primary_10_1002_jnr_24752 crossref_primary_10_1002_mco2_26 crossref_primary_10_1097_FCH_0000000000000082 crossref_primary_10_1038_srep17554 crossref_primary_10_1093_infdis_jiv499 crossref_primary_10_1016_j_scitotenv_2020_143352 crossref_primary_10_1111_irv_12173 crossref_primary_10_1016_j_jiph_2021_08_015 crossref_primary_10_1099_vir_0_059014_0 crossref_primary_10_4193_Rhin20_610 crossref_primary_10_1097_MCP_0000000000000153 crossref_primary_10_1186_s12879_017_2253_8 crossref_primary_10_4103_ijcm_ijcm_460_22 crossref_primary_10_1128_JVI_00099_20 crossref_primary_10_3390_v13061139 crossref_primary_10_1016_j_jiph_2017_08_009 crossref_primary_10_1186_s12985_016_0479_5 crossref_primary_10_1007_s12275_017_7026_y crossref_primary_10_1016_j_prrv_2015_04_002 crossref_primary_10_1016_j_ajpath_2015_09_014 crossref_primary_10_1073_pnas_2410630122 crossref_primary_10_7554_eLife_66417 crossref_primary_10_1016_j_vetmic_2019_06_001 crossref_primary_10_1111_ene_14277 crossref_primary_10_1016_j_clinmicnews_2014_07_002 crossref_primary_10_1016_j_virusres_2016_11_011 crossref_primary_10_3390_v11010059 crossref_primary_10_1128_JVI_03036_15 crossref_primary_10_3390_v11030280 |
Cites_doi | 10.2217/17460794.4.1.71 10.1186/1743-422X-10-66 10.1111/j.1750-2659.2010.00155.x 10.1073/pnas.0711942105 10.1182/blood-2004-10-4166 10.1016/S0140-6736(03)13973-6 10.1001/jama.290.24.3222 10.1128/JVI.01782-06 10.1128/JVI.79.24.15511-15524.2005 10.2807/ese.17.40.20290-en 10.1165/rcmb.2012-0339OC 10.1080/00365540410021144 10.1128/JVI.79.12.7819-7826.2005 10.1016/j.virol.2004.08.011 10.1016/j.antiviral.2011.07.011 10.1371/journal.pmed.0030027 10.1038/nm1529 10.1128/JVI.05662-11 10.1056/NEJMoa1211721 10.1016/j.antiviral.2010.11.007 10.1086/382597 10.1373/clinchem.2003.023663 10.1371/journal.ppat.1000756 10.1016/S0140-6736(02)11772-7 10.1371/journal.ppat.1002705 10.1128/JCM.02614-05 10.1128/JVI.06189-11 10.1128/mBio.00611-12 10.1371/journal.pone.0013927 10.1016/j.coviro.2012.04.004 10.2807/ese.17.39.20282-en 10.2807/ese.17.39.20285-en 10.1007/BF00194614 10.1016/j.jinf.2012.10.002 10.1128/mBio.00473-12 10.1038/nm1001 10.3201/eid1903.121503 10.2353/ajpath.2010.091087 10.1006/meth.2001.1262 10.1016/j.virol.2007.09.045 10.1038/nm1024 |
ContentType | Journal Article |
Copyright | Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 7U9 H94 5PM |
DOI | 10.1128/JVI.00009-13 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 6614 |
ExternalDocumentID | PMC3676115 23552422 10_1128_JVI_00009_13 jvi_87_12_6604 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI075297 – fundername: NIAID NIH HHS grantid: U54-AI057157 – fundername: NIAID NIH HHS grantid: R01AI085524 – fundername: NIAID NIH HHS grantid: U54 AI057157 – fundername: NIAID NIH HHS grantid: R01 AI085524 – fundername: NIAID NIH HHS grantid: R01AI075297 |
GroupedDBID | --- -~X 0R~ 18M 29L 2WC 39C 4.4 53G 5GY 5RE 5VS 85S AAFWJ AAGFI AAYXX ABPPZ ACGFO ACNCT ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 N9A O9- OK1 P2P RHI RNS RPM RSF TR2 UPT W2D W8F WH7 WOQ YQT ~02 ~KM .55 .GJ 3O- 41~ 6TJ AAYJJ ADXHL AFFNX AI. C1A CGR CUY CVF D0S ECM EIF MVM NPM OHT VH1 X7M Y6R ZGI ZXP 7X8 7T5 7U9 H94 5PM |
ID | FETCH-LOGICAL-c444t-3aa32b14e3a4bd52a045318ddd525cadea20a5f26c3285357c5b30ef2d1379053 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 17:44:28 EDT 2025 Thu Jul 10 19:12:11 EDT 2025 Fri Jul 11 08:14:23 EDT 2025 Mon Jul 21 05:57:22 EDT 2025 Thu Apr 24 23:06:35 EDT 2025 Tue Jul 01 01:02:23 EDT 2025 Wed May 18 15:26:13 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c444t-3aa32b14e3a4bd52a045318ddd525cadea20a5f26c3285357c5b30ef2d1379053 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 R.W.Y.C. and M.C.W.C. contributed equally to this article. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3676115 |
PMID | 23552422 |
PQID | 1356955312 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1356955312 crossref_citationtrail_10_1128_JVI_00009_13 proquest_miscellaneous_1443373008 highwire_asm_jvi_87_12_6604 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3676115 pubmed_primary_23552422 crossref_primary_10_1128_JVI_00009_13 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-06-01 |
PublicationDateYYYYMMDD | 2013-06-01 |
PublicationDate_xml | – month: 06 year: 2013 text: 2013-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2013 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 WHO (e_1_3_2_13_2) 2012 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 Chan MC (e_1_3_2_7_2) 2011; 17 38497665 - J Virol. 2024 Mar 18;:e0037924 |
References_xml | – ident: e_1_3_2_4_2 doi: 10.2217/17460794.4.1.71 – ident: e_1_3_2_15_2 – ident: e_1_3_2_16_2 doi: 10.1186/1743-422X-10-66 – ident: e_1_3_2_40_2 doi: 10.1111/j.1750-2659.2010.00155.x – ident: e_1_3_2_41_2 doi: 10.1073/pnas.0711942105 – ident: e_1_3_2_3_2 doi: 10.1182/blood-2004-10-4166 – ident: e_1_3_2_43_2 doi: 10.1016/S0140-6736(03)13973-6 – ident: e_1_3_2_44_2 doi: 10.1001/jama.290.24.3222 – ident: e_1_3_2_42_2 doi: 10.1128/JVI.01782-06 – ident: e_1_3_2_6_2 doi: 10.1128/JVI.79.24.15511-15524.2005 – ident: e_1_3_2_11_2 doi: 10.2807/ese.17.40.20290-en – ident: e_1_3_2_10_2 doi: 10.1165/rcmb.2012-0339OC – ident: e_1_3_2_24_2 doi: 10.1080/00365540410021144 – ident: e_1_3_2_2_2 doi: 10.1128/JVI.79.12.7819-7826.2005 – ident: e_1_3_2_27_2 doi: 10.1016/j.virol.2004.08.011 – ident: e_1_3_2_39_2 doi: 10.1016/j.antiviral.2011.07.011 – ident: e_1_3_2_9_2 doi: 10.1371/journal.pmed.0030027 – ident: e_1_3_2_30_2 doi: 10.1038/nm1529 – ident: e_1_3_2_23_2 doi: 10.1128/JVI.05662-11 – ident: e_1_3_2_12_2 doi: 10.1056/NEJMoa1211721 – ident: e_1_3_2_26_2 doi: 10.1016/j.antiviral.2010.11.007 – ident: e_1_3_2_29_2 doi: 10.1086/382597 – ident: e_1_3_2_32_2 doi: 10.1373/clinchem.2003.023663 – ident: e_1_3_2_28_2 doi: 10.1371/journal.ppat.1000756 – ident: e_1_3_2_33_2 doi: 10.1016/S0140-6736(02)11772-7 – ident: e_1_3_2_35_2 doi: 10.1371/journal.ppat.1002705 – ident: e_1_3_2_20_2 doi: 10.1128/JCM.02614-05 – ident: e_1_3_2_34_2 doi: 10.1128/JVI.06189-11 – ident: e_1_3_2_37_2 doi: 10.1128/mBio.00611-12 – volume-title: Background and summary of novel coronavirus infection year: 2012 ident: e_1_3_2_13_2 – volume: 17 start-page: 31 year: 2011 ident: e_1_3_2_7_2 article-title: Pathogenesis of SARS coronavirus infection using human lung epithelial cells: an in vitro model publication-title: Hong Kong Med. J – ident: e_1_3_2_45_2 doi: 10.1371/journal.pone.0013927 – ident: e_1_3_2_5_2 doi: 10.1016/j.coviro.2012.04.004 – ident: e_1_3_2_14_2 doi: 10.2807/ese.17.39.20282-en – ident: e_1_3_2_19_2 doi: 10.2807/ese.17.39.20285-en – ident: e_1_3_2_38_2 doi: 10.1007/BF00194614 – ident: e_1_3_2_18_2 doi: 10.1016/j.jinf.2012.10.002 – ident: e_1_3_2_36_2 doi: 10.1128/mBio.00473-12 – ident: e_1_3_2_25_2 doi: 10.1038/nm1001 – ident: e_1_3_2_17_2 doi: 10.3201/eid1903.121503 – ident: e_1_3_2_22_2 doi: 10.2353/ajpath.2010.091087 – ident: e_1_3_2_31_2 doi: 10.1006/meth.2001.1262 – ident: e_1_3_2_8_2 doi: 10.1016/j.virol.2007.09.045 – ident: e_1_3_2_21_2 doi: 10.1038/nm1024 – reference: 38497665 - J Virol. 2024 Mar 18;:e0037924 |
SSID | ssj0014464 |
Score | 2.4883578 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C... |
SourceID | pubmedcentral proquest pubmed crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 6604 |
SubjectTerms | Bronchi - cytology Bronchi - virology Cell Line Coronavirus - drug effects Coronavirus - genetics Coronavirus - immunology Coronavirus - physiology Coronavirus 229E, Human - physiology Coronavirus Infections - immunology Coronavirus Infections - virology Epithelial Cells - virology Human coronavirus 229e Humans Immunity, Innate Interferons - pharmacology Lung - cytology Lung - virology Organ Culture Techniques Receptors, Coronavirus Receptors, Virus - metabolism SARS coronavirus Severe Acute Respiratory Syndrome - immunology Severe Acute Respiratory Syndrome - virology Severe acute respiratory syndrome-related coronavirus - physiology Viral Tropism Virus Replication Virus-Cell Interactions |
Title | Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures |
URI | http://jvi.asm.org/content/87/12/6604.abstract https://www.ncbi.nlm.nih.gov/pubmed/23552422 https://www.proquest.com/docview/1356955312 https://www.proquest.com/docview/1443373008 https://pubmed.ncbi.nlm.nih.gov/PMC3676115 |
Volume | 87 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiQuiDehgBYJTpZDsg_HPpYoqCktB2hLOVnrFxgaO3KcqHDnr_I7mFmvHbstFXCxHO9ms858np3xznxDyAtY9EQwTJgdJBG3BbjXthe4iR1wJ5JcuDyMcUf34J2zeyT2TuRJr_erFbW0KoNB-OPSvJL_kSpcA7liluw_SLYZFC7AOcgXjiBhOP6djIt8gUUucC9fh_VmYDlaM0z5wHIMOvq1onDQoYz5Oj41b-1fxyWowgLM8HVarJbomscYvTOxjvVnZMDSHadncGWd69HqLXmdv2nIOE0I4kXzFsbpvLF_D0o1tj4OrE8DndLQSLqK27cmA2xst3xYRV_UN1VYO5-zFDPFCjWv2_bzVbpU1n53OPP2QleS6ESC1NtS7RjVg3TDQdXW3eg2c12IGFauSl0jGyrafG19bhZwg1vW0s6OU5U6vrhsMEyF2DueaTpLz67SY1sIWsw1hBhYZ2DTsM3iWQcMnFtTm0jHr-vUd8f-iPn449fIdQbujHb9Z2-b3S5wyUXNao93WCdoMPdVe05IXG0m0LWiambry7yk88G-Levp8Da5ZXBBdyoM3yG9OLtLblSFUL_fIz8NkmmeUEAyrZBMKyTTBsm0zCkgmWokUw1Qeg7J1CCZTqhGMk0z03F6RhHJtIVkqpFMayTfJ0dvpoeTXdsUCLFDIURpc6U4C0Yi5koEkWQK_BNYo6IIziWmlyg2VDJhTsgZmKVyHMqAD-OERSOOxHT8AdnK8ix-ROhYymgskkQqNxQwqDdkXhC6kYcmvgpGfWLVf7gfGvZ8LOJy6msvmrk-SMrXkvJHvE9eNr0XFWvMH_pt17Lz1XLud9HSJ89rcfqg9HEnT2VxvlrCN6XjSbhXdkUfITjHahRunzysINDMpYZRn4w74Gg6IOl8twUedE0-jwyP4EU-vnLm2-Tm5mF_QrbKYhU_BeO9DJ5p5P8G1CHxeg |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tropism+of+and+Innate+Immune+Responses+to+the+Novel+Human+Betacoronavirus+Lineage+C+Virus+in+Human+Ex+Vivo+Respiratory+Organ+Cultures&rft.jtitle=Journal+of+Virology&rft.au=Renee+W.+Y.+Chan&rft.au=Michael+C.+W.+Chan&rft.au=Sudhakar+Agnihothram&rft.au=Louisa+L.+Y.+Chan&rft.date=2013-06-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=87&rft.issue=12&rft.spage=6604&rft_id=info:doi/10.1128%2FJVI.00009-13&rft_id=info%3Apmid%2F23552422&rft.externalDBID=n%2Fa&rft.externalDocID=jvi_87_12_6604 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |